The present SARS Cov-2 pandemic represented an unprecedented challenge for both public health and the economy around the world.
In line with the extraordinary measures taken by Governments and other international Organizations to mitigate the pandemic spread, Freia Farmaceutici has strengthened its commitment to its people, patients and involved communities, adopting appropriate safety protocols and dedicated training programs.
Freia Farmaceutici has also activated specific clinical research lines to identify new therapeutic solutions with a low economic impact and to control inflammatory processes associated with SARS Cov-2 infection.
Lastly, a specific product line was developed to ensure adequate procedures for hands and work surfaces sanitation as indicated by the World Health Organization.
